Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
- beauty
- cleaning
- pharma
Medium-chain triglycerides
EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.
Concern score
Not assessed — no hazard data yet.
Where it appears
Prevalence of Medium-chain triglycerides in our catalog (epa_cpdat).
Products
12
Brands
6
Personal care
See products using Medium-chain triglycerides →Found in these products
Chewy spicy candies
Hot Tamale, Hot Tamales
CriticalOH OH COOKIE DOUGH
TRUBAR
MinorSour Cream & Onion Flavored Potato Chips
Lay's
Highmac & cheese
Kraft
HighPB & Jelly Protein Bar
TruBar
Minormac & cheese
Kraft
MinorGenuine Protein Powder
Muscle Milk
MinorHigh strength multivitamin & minerals for women and men
VitaBright
MinorProhance - HP Vanilla Flavour
Prohance
MinorOne A Day Women's
Bayer
MinorCentrum Silver Men 50+
Centrum
CriticalShells & Cheese Original
Velveeta
Highmacaroni & cheese sauce mix
Kraft
HighLay's Barbecue Flavored Potato Chips
Lay's
CriticalMonster Energy Ultra, Peachy Keen, Sugar Free
MONSTER ENERGY
MinorViking berry
Monster
HighPROTEIN SHAKE
MUSCLE MILK
MinorAll-in-One Shake
goodprotein
MinorFierce Cinnamon Flavored Chewy Candies
Hot Tamales
ModerateProtein Powder Supplement
Muscle Milk
HighProtein bar
CriticalVitamin D3+K2 Daily Oral Spray
Better You, BetterYou
MinorOrganic MCT Oil 100% MCTS
Nature's Way,GreenLife
Moderatemike pue ike nega mix
Mike And Ike
Critical
Often appears with
Ingredients that frequently appear alongside Medium-chain triglycerides in the catalog.
- Glyceryl caprylate caprate
- Medium-chain triglycerides
- Maltodextrin
- Anhydrous trisodium citrate
- Sodium citrate (x:1)
- Disodium hydrogen citrate
- Sodium citrate, unspecified form
- Trisodium citrate dihydrate
- Whey
- Starch, 2-hydroxy-3-(trimethylammonio)propyl ether, chloride
- Lecithins, polymers with glycerol, oiticica oil, phthalic anhydride and soybean oil
- Lecithins, soya
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Good fit
Evidence
No graded sources yet for Medium-chain triglycerides. We publish evidence only once a source is linked and reviewed — this ingredient is in the catalog, but has not been assessed.
Regulatory status
No restrictions found. Medium-chain triglycerides appears in these published regulatory listings.
USFDAinactive ingredient database19 entries — 6 administration routes
- Route: INTRAVENOUS; Dosage form: INJECTION, EMULSION; Potency: 1.1 %w/vSource →
- Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 4771 mgSource →
- Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 866 mgSource →
- Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Potency: 3390 mg/5mlSource →
- Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 5566 mgSource →
- Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 10170 mgSource →
- Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 2 mgSource →
- Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Potency: 0.37 mgSource →
- Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 1 mgSource →
- Route: SUBCUTANEOUS; Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 990 mgSource →
- Route: SUBLINGUAL; Dosage form: POWDER; Maximum daily exposure: 2 mgSource →
- Route: SUBLINGUAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 110 mgSource →
- Route: TOPICAL; Dosage form: AEROSOL, FOAM; Potency: 10.87 %w/wSource →
- Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 570 mgSource →
- Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 12 mgSource →
- Route: TOPICAL; Dosage form: LOTION; Potency: 7 %w/wSource →
- Route: TOPICAL; Dosage form: OINTMENT; Potency: 20 %w/wSource →
- Route: TOPICAL; Dosage form: SPRAY; Maximum daily exposure: 540 mgSource →
- Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NASource →
USEPAcommercial use observedEPA CPDat observed this chemical in 12 composition records across product categories including Personal care.
- EPA CPDat observed this chemical in 12 composition records across product categories including Personal care.Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 1 active drug products and 4 total products.
- FDA NDC lists this ingredient in 1 active drug products and 4 total products.Source →